Resonant Medical develops, manufactures and commercializes 3D ultrasound adaptive radiotherapy products for cancer centers – with the goal to enable fundamental improvements to treatment planning, verification and delivery, for the advancement of patient care.
Precise tumor localization and fast and accurate patient
Resonant Medical’s products provide a robust and innovative solution to the problems of organ motion during the course of treatment and lower resolution soft-tissue visualization on CT.
Resonant’s system consists of RESTITU U/S-SIM™ in the
RESTITU™’s ergonomic hardware and high-performance software platform features significant technological advances in 3D ultrasound imaging technology, such as IMPLICIT REGISTRATION™ and MUTUAL REFERENCING™ – opening the door to a number of possible improvements in treatment planning and delivery.
Here is how RESTITU™ works: The radiation therapist acquires high-quality, reconstructed 3D ultrasound volumetric data – in a matter of seconds and with minimum effort. Then, with assisted segmentation, the volume of the targeted organ and structures-at-risk is quickly segmented. Organ displacement is accurately calculated to restore the target to its intended planned position. Patient alignment (target position, shape and size) is validated through a beam’s-eye view with MLC overlay. Powerful visualization tools on the RESTITU™ Workstation allow the physician to analyze volumetric information in 3D, and persistent data enables treatment progress monitoring.
RESTITU™’s key advantages
While making position verification and patient positioning possible, without compromising throughput, RESTITU™ allows the medical team to:
• Improve soft-tissue organ definition
RESTITU U/S-SIM™ is the 3D ultrasound system used in the CT-Sim room for target volume delineation and "positional reference volume" definition.
Since the RESTITU™ system is also expandable to other anatomical sites, the future of ultrasound as an adjunct imaging modality is promising.
In the treatment room, RESTITU U/S-GUIDE™ makes tumor position verification and patient positioning possible without compromising throughput. Thanks to Resonant’s patented MUTUAL REFERENCING™ technology, it delivers robust and reproducible 3D ultrasound imaging, tumor position verification and patient re-alignment in only 90 seconds. RESTITU U/S-GUIDE™ greatly improves the physician’s confidence in treatment accuracy, while addressing patient throughput.
For example, just to name a few, the image-acquisition phase provides the therapist with imaging presets and reference images from previous treatment days. The system makes it possible to repeat any step in the workflow rather than starting from the beginning. Most importantly, RESTITU™’s patient alignment feature provides automatic displacement calculation through our unique, patented MUTUAL REFERENCING™ technology, as well as patent-pending surface-matching algorithms. During this step, real-time feedback of the organ position in the three orthogonal planes and all beam’s-eye views provides further confidence in displacement corrections. The result – rapid, confident repositioning of the patient.
RESTITU™ Workstation assists the physician by performing four major tasks, as well as many sub-tasks:
Definition of reference target volumes
RESTITU™ Workstation allows the physician to review, refine and approve reference target volumes. The reference target volume is used as the basis for subsequent comparison on the RESTITU U/S-GUIDE™ through MUTUAL REFERENCING™.
Improved target definition
The Workstation allows IMPLICIT REGISTRATION™ and automatic fusion of CT and RESTITU™ U/S-SIM™ data for improved organ definition.
Review of patient data
RESTITU™ Workstation provides powerful, proprietary tools to access, visualize and analyze volumetric patient information in 3D acquired during any previous treatment session – from the convenience of any office in the cancer center.
The Workstation allows review of all images acquired at the RESTITU U/S-SIM™ or RESTITU U/S-GUIDE™ stages – individually or in 3D reconstruction mode, as well as statistical information, time-series and trend analyses.
Access to patient data
Conveniently access patient data acquired during any previous treatment session and stored on the RESTITU™ server.
Access to persistent patient data from the desktop – using RESTITU™’s secure, web-browser-based retrieval system – facilitates individual as well as multidisciplinary clinical and research collaborations.
Data is readily available to generate progress reports or for statistical analysis in research-friendly (CSV, XLS) or immutable formats (pdf). In addition, this data can be accessed and reviewed in multiple report formats from any office in your institution.
High-capacity storage or retrieval from archived data is possible, thereby providing a rich source of information for research or statistical purposes.
RESTITU™’s unique hardware – for high performance and quality…
Resonant currently has several patents pending for its proprietary technology.